ToolAssay

Lyon 2020 HFA-ICOS baseline cardiovascular risk before HER2-targeted therapy (tr

Lyon 2020 HFA-ICOS baseline cardiovascular risk before HER2-targeted therapy (trastuzumab and related agents). Very high, high, medium, or low from published factors plus Medium 1/2 points; expert-opinion cardiotoxicity guide <2% / 2-9% / 10-19% / >=20%. Concurrent anthracycline is High; sequential anthracycline before HER2 is Medium 1. Deterministic published classification with citation; not a treatment order. magent does not measure LVEF or biomarkers.

Asked 1.4x its listed price for its own exampleour last check, 2026-09-28
1 of 1checks answered this week
334 msmedian answer time
$0.005listed price per call
$0.007price it asked us

Paid test badge: not yet. The checks above are free: we call the tool without paying and read the payment request it sends back. The Verified badge needs paid calls whose answers match the promised output, and nobody can buy a badge.

Endpoint

POST https://api.magentlab.com/api/calc/hfa_icos_her2

CategoryEverything else
Provider hostapi.magentlab.com
Networkseip155:8453
Payment schemesexact
Self-reported calls, 30 days0 from 0 payers (the provider's figure, not ours)

Our checks, last 30 days

DayResultHTTPAskedTime
2026-09-28 valid payment request 402$0.007 334 ms

Example input (from the provider)

{
  "body": {
    "items": [
      {
        "age_years": 50,
        "anthracycline_before_her2": false,
        "arrhythmia": false,
        "ckd": false,
        "concurrent_anthracycline_and_her2": false,
        "current_or_significant_smoker": false,
        "diabetes": false,
        "elevated_bnp": false,
        "elevated_troponin": false,
        "heart_failure_or_cardiomyopathy": false,
        "hypertension": false,
        "lvef_percent": 60,
        "mi_or_cabg": false,
        "obesity": false,
        "prior_left_chest_or_mediastinal_rt": false,
        "prior_remote_anthracycline": false,
        "prior_trastuzumab_cardiotoxicity": false,
        "severe_valvular_heart_disease": false,
        "stable_angina": false
      },
      {
        "age_years": 50,
        "anthracycline_before_her2": false,
        "arrhythmia": false,
        "ckd": false,
        "concurrent_anthracycline_and_her2": false,
        "current_or_significant_smoker": false,
        "diabetes": false,
        "elevated_bnp": false,
        "elevated_troponin": false,
        "heart_failure_or_cardiomyopathy": false,
        "hypertension": false,
        "lvef_percent": 60,
        "mi_or_cabg": false,
        "obesity": false,
        "prior_left_chest_or_mediastinal_rt": false,
        "prior_remote_anthracycline": false,
        "prior_trastuzumab_cardiotoxicity": false,
        "severe_valvular_heart_disease": false,
        "stable_angina": false
      }
    ]
  },
  "method": "POST",
  "type": "http"
}

Promised output schema (from the provider)

{
  "$schema": "https://json-schema.org/draft/2020-12/schema",
  "properties": {
    "input": {
      "additionalProperties": false,
      "properties": {
        "body": {
          "additionalProperties": false,
          "properties": {
            "items": {
              "items": {
                "properties": {
                  "age_years": {
                    "description": "Age in years (integer 18-100). Lyon 2020 exclusive bands: \u226580 is High; 65-79 is Medium 2 (2 points); younger than 65 does not score. Age 80 is High, not Medium 2.",
                    "type": "integer"
                  },
                  "anthracycline_before_her2": {
                    "description": "Current regimen includes anthracycline before HER2-targeted therapy, sequential not concurrent (Lyon 2020 HER2 table Medium 1). true or false. Ignored for points when concurrent_anthracycline_and_her2 is true.",
                    "type": "boolean"
                  },
                  "arrhythmia": {
                    "description": "Atrial fibrillation, atrial flutter, VT, or VF as assigned by the caller (Lyon 2020 HER2 table Medium 2). true or false. magent does not interpret the ECG.",
                    "type": "boolean"
                  },
                  "ckd": {
                    "description": "Chronic kidney disease as assigned by the caller (Lyon 2020 HER2 table Medium 1). true or false.",
                    "type": "boolean"
                  },
                  "concurrent_anthracycline_and_her2": {
                    "description": "Anthracycline and trastuzumab delivered concurrently on the current protocol (Lyon 2020 HER2 table footnote f; High). true or false. When true, anthracycline_before_her2 does not add Medium 1 points.",
                    "type": "boolean"
                  },
                  "current_or_significant_smoker": {
                    "description": "Current or significant smoking history as assigned by the caller (Lyon 2020 HER2 table Medium 1). true or false.",
                    "type": "boolean"
                  },
                  "diabetes": {
                    "description": "Diabetes mellitus as assigned by the caller (Lyon 2020 HER2 table Medium 1). true or false.",
                    "type": "boolean"
                  },
                  "elevated_bnp": {
                    "description": "Elevated BNP or NT-proBNP as assigned by the caller (Lyon 2020 HER2 table Medium 2). true or false. magent does not assay natriuretic peptides.",
                    "type": "boolean"
                  },
                  "elevated_troponin": {
                    "description": "Elevated troponin as assigned by the caller (Lyon 2020 HER2 table Medium 2). true or false. magent does not assay troponin.",
                    "type": "boolean"
                  },
                  "heart_failure_or_cardiomyopathy": {
                    "description": "Heart failure or cardiomyopathy as assigned by the caller (Lyon 2020 HER2 table Very high). true or false.",
                    "type": "boolean"
                  },
                  "hypertension": {
                    "description": "Hypertension as assigned by the caller (Lyon 2020 HER2 table Medium 1). true or false.",
                    "type": "boolean"
                  },
                  "lvef_percent": {
                    "description": "Left-ventricular ejection fraction percent (integer 10-80) as assigned by the caller. <50 is High; 50-54 is Medium 2 (2 points); \u226555 does not score. magent does not measure LVEF.",
                    "type": "integer"
                  },
                  "mi_or_cabg": {
                    "description": "Prior myocardial infarction or CABG as assigned by the caller (Lyon 2020 HER2 table High). true or false.",
                    "type": "boolean"
                  },
                  "obesity": {
                    "description": "Obesity as assigned by the caller (Lyon 2020 HER2 table Medium 1). true or false. magent does not compute BMI.",
                    "type": "boolean"
                  },
                  "prior_left_chest_or_mediastinal_rt": {
                    "description": "Prior left-chest or mediastinal radiotherapy as assigned by the caller (Lyon 2020 HER2 table Medium 2). true or false.",
                    "type": "boolean"
                  },
                  "prior_remote_anthracycline": {
                    "description": "Prior remote anthracycline for a previous malignancy, not the current protocol (Lyon 2020 HER2 table footnote g; Medium 2). true or false.",
                    "type": "boolean"
                  },
                  "prior_trastuzumab_cardiotoxicity": {
                    "description": "Prior trastuzumab cardiotoxicity as assigned by the caller (Lyon 2020 HER2 table Very high). true or false. magent does not review prior exposure.",
                    "type": "boolean"
                  },
                  "severe_valvular_heart_disease": {
                    "description": "Severe valvular heart disease as assigned by the caller (Lyon 2020 HER2 table High). true or false.",
                    "type": "boolean"
                  },
                  "stable_angina": {
                    "description": "Stable angina as assigned by the caller (Lyon 2020 HER2 table High). true or false.",
                    "type": "boolean"
                  }
                },
                "required": [
                  "age_years",
                  "lvef_percent",
                  "heart_failure_or_cardiomyopathy",
                  "prior_trastuzumab_cardiotoxicity",
                  "mi_or_cabg",
                  "stable_angina",
                  "severe_valvular_heart_disease",
                  "concurrent_anthracycline_and_her2",
                  "arrhythmia",
                  "elevated_troponin",
                  "elevated_bnp",
                  "prior_remote_anthracycli

This page as JSON